2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 42.364 | 46.196 | 45.064 | 41.548 | 31.651 | 20.060 | 13.645 | 14.555 | 21.900 | 30.625 |
Total Income - EUR | 42.364 | 46.196 | 45.064 | 41.548 | 31.654 | 64.552 | 29.449 | 14.557 | 21.900 | 30.625 |
Total Expenses - EUR | 19.434 | 22.841 | 23.830 | 68.502 | 23.955 | 60.485 | 22.016 | 13.689 | 16.929 | 26.038 |
Gross Profit/Loss - EUR | 22.930 | 23.355 | 21.235 | -26.954 | 7.699 | 4.067 | 7.433 | 868 | 4.971 | 4.587 |
Net Profit/Loss - EUR | 21.659 | 21.973 | 19.870 | -28.199 | 7.118 | 3.407 | 7.138 | 722 | 4.752 | 4.281 |
Employees | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Fructomed Sa
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 330.343 | 327.739 | 319.090 | 308.473 | 297.691 | 255.125 | 224.894 | 230.621 | 226.867 | 349.489 |
Current Assets | 137.498 | 164.825 | 187.552 | 160.401 | 170.932 | 186.155 | 200.186 | 183.133 | 193.677 | 75.949 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 137.389 | 164.642 | 185.924 | 160.017 | 169.896 | 146.113 | 196.490 | 182.756 | 193.223 | 52.183 |
Cash | 109 | 183 | 1.628 | 385 | 1.037 | 40.042 | 3.696 | 376 | 454 | 23.766 |
Shareholders Funds | 462.860 | 488.696 | 503.582 | 466.861 | 465.412 | 436.772 | 418.927 | 410.359 | 416.384 | 419.402 |
Social Capital | 39.426 | 39.755 | 39.350 | 38.684 | 37.974 | 37.239 | 36.533 | 35.722 | 35.833 | 35.725 |
Debts | 4.982 | 3.868 | 3.059 | 2.013 | 3.211 | 4.507 | 6.153 | 3.395 | 4.160 | 6.036 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4721 - 4721" | |||||||||
CAEN Financial Year |
4721
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Fructomed Sa